Lini Pandite
Directeur Technique/Scientifique/R&D chez SHATTUCK LABS, INC.
Fortune : 479 068 $ au 30/06/2024
Profil
Lini Pandite is currently the Chief Medical Officer at Shattuck Labs, Inc. Prior to this, Lini held positions as an Independent Director at Codiak BioSciences, Inc., Vice President at GSK Plc, Vice President-Research & Development at GlaxoSmithKline LLC, and Head-Global Clinical Development & Senior VP at Adaptimmune Therapeutics Plc.
Lini obtained a doctorate degree from The University of Liverpool and an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHATTUCK LABS, INC.
0,26% | 01/04/2024 | 124 111 ( 0,26% ) | 479 068 $ | 30/06/2024 |
Postes actifs de Lini Pandite
| Sociétés | Poste | Début |
|---|---|---|
| SHATTUCK LABS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2017 |
Anciens postes connus de Lini Pandite
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 01/06/2017 |
| GSK PLC | Corporate Officer/Principal | 01/04/2015 |
| CODIAK BIOSCIENCES | Directeur/Membre du Conseil | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Directeur Technique/Scientifique/R&D | - |
Formation de Lini Pandite
| The University of Liverpool | Doctorate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SHATTUCK LABS, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
